Albumin companies

Key Albumin Market Players:

The worldwide market is vigorously gaining increased exposure with the presence of leading organizations, including Takeda, Grifols, and CSL Behring, collectively controlling the market with a combined share. These players have readily implemented strategies, such as biopharmaceutical partnerships and collaboration, research and development activities for recombinant albumin, plasma self-sufficiency, and market penetration. For instance, Seqirus and Baxter successfully partnered with each other to supply albumin for mRNA vaccine stabilizers. Likewise, LFB Group and Takeda initiated an investment for yeast-based alternatives to albumin, thereby creating a positive influence on the overall market.

Here is a list of key players operating in the market:

• CSL Behring (U.S.)
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis
• Grifols (Spain)
• Takeda Pharmaceuticals (U.S.)
• Octapharma (Switzerland)
• Baxter International (U.S.)
• Kedrion Biopharma (Italy)
• Biotest (Germany)
• LFB Group (France)
• Sanquin (Netherlands)
• Bio Products Laboratory (UK)
• SK Plasma (South Korea)
• Biological E. Ltd. (India)
• Serum Institute of India
• Protheragen (Malaysia)
• Seqirus (Australia)